PRESS RELEASE published on 12/17/2025 at 22:05, 1 month 18 days ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques Abivax Obefazimod MICI ECCO 2026 Présentation Orale
PRESS RELEASE published on 12/17/2025 at 22:05, 1 month 18 days ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Abivax announces acceptance of 22 abstracts evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, featuring oral presentation on preclinical anti-fibrotic findings Abivax Obefazimod Preclinical Study Inflammatory Bowel Disease ECCO 2026
BRIEF published on 12/15/2025 at 22:10, 1 month 20 days ago Abivax: Third Quarter 2025 Financial Results Financial Results Treasury Abivax Net Loss R&D Expenditures
BRIEF published on 12/15/2025 at 22:10, 1 month 20 days ago Abivax : Résultats financiers du troisième trimestre 2025 Résultats Financiers Abivax Trésorerie Perte Nette Dépenses R&D
BRIEF published on 12/15/2025 at 22:10, 1 month 20 days ago Abivax publie ses résultats financiers du troisième trimestre 2025 Dépenses De R&D Financement Des Biotechnologies Abivax Financials Résultats Du Troisième Trimestre 2025 Position De Trésorerie
BRIEF published on 12/15/2025 at 22:10, 1 month 20 days ago Abivax Reports Third Quarter 2025 Financial Results Cash Position Biotech Funding R&D Expenses Q3 2025 Results Abivax Financials
PRESS RELEASE published on 12/15/2025 at 22:05, 1 month 20 days ago Abivax présente ses résultats financiers du troisième trimestre 2025 Abivax présente ses résultats financiers du troisième trimestre 2025 avec trésorerie de 589,7 millions d'euros et une autonomie financière jusqu'au quatrième trimestre 2027 Résultats Financiers Abivax Troisième Trimestre Autonomie Financière 589,7 Millions D'euros
PRESS RELEASE published on 12/15/2025 at 22:05, 1 month 20 days ago Abivax Presents Third Quarter 2025 Financial Results Abivax presents its third quarter 2025 financial results with EUR 589.7 cash and cash equivalents, providing key updates on its business and operational goals Financial Results Abivax Third Quarter Operational Goals Cash Equivalents
BRIEF published on 12/12/2025 at 18:05, 1 month 23 days ago ABIVAX : Publication des Données Capital et Droits de Vote au 30 Novembre 2025 Droits De Vote Capital Social Abivax Réglementation AMF Informations Financières
BRIEF published on 12/12/2025 at 18:05, 1 month 23 days ago ABIVAX: Publication of Capital and Voting Rights Data as of November 30, 2025 Financial Information Share Capital Voting Rights Abivax AMF Regulations
Published on 02/05/2026 at 01:35, 1 hour 32 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 3 hours 7 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 4 hours 42 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 10 hours 52 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 6 hours 13 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 6 hours 31 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 7 hours 7 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 8 hours 12 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 8 hours 27 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 9 hours 3 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 9 hours 22 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 9 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL